Ditchcarbon
  • Contact
  1. Organizations
  2. Ferring Pharmaceuticals Inc.
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated a month ago

Ferring Pharmaceuticals Inc. Sustainability Profile

Company website

Ferring Pharmaceuticals Inc., a global biopharmaceutical company, is headquartered in the United States and operates extensively across Europe, Asia, and Latin America. Founded in 1950, Ferring has established itself as a leader in reproductive health, urology, and gastroenterology, focusing on innovative therapies that address unmet medical needs. The company is renowned for its core products, including hormone therapies and treatments for various gastrointestinal disorders, which are distinguished by their patient-centric approach and commitment to research and development. Ferring's dedication to advancing healthcare has positioned it as a notable player in the biopharmaceutical industry, with significant achievements in clinical research and a robust pipeline of therapies aimed at improving patient outcomes.

DitchCarbon Score

How does Ferring Pharmaceuticals Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

34

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Ferring Pharmaceuticals Inc.'s score of 34 is higher than 57% of the industry. This can give you a sense of how well the company is doing compared to its peers.

57%

Let us know if this data was useful to you

Ferring Pharmaceuticals Inc.'s reported carbon emissions

Ferring Pharmaceuticals Inc., headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Ferring Holding SA, which may influence its climate commitments and reporting practices. Ferring Pharmaceuticals has not established specific reduction targets or initiatives, as there are no documented SBTi (Science Based Targets initiative) or CDP (Carbon Disclosure Project) reduction targets available. This lack of data suggests that the company may still be in the early stages of developing its climate strategy. As a subsidiary, Ferring Pharmaceuticals may align its climate commitments with those of its parent company, Ferring Holding SA. However, without specific emissions data or reduction targets, it is challenging to assess the company's current impact on climate change or its future commitments. In summary, Ferring Pharmaceuticals Inc. has not disclosed any carbon emissions data or specific climate commitments, reflecting a potential area for development in their sustainability strategy.

How Carbon Intensive is Ferring Pharmaceuticals Inc.'s Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Ferring Pharmaceuticals Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Ferring Pharmaceuticals Inc.'s Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Ferring Pharmaceuticals Inc. is in US, which has a low grid carbon intensity relative to other regions.

Ferring Pharmaceuticals Inc.'s Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Ferring Pharmaceuticals Inc. has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Ferring Pharmaceuticals Inc.'s Emissions with Industry Peers

Bausch Health Cos

CA
•
Pharmaceutical Preparation Manufacturing
Updated about 1 hour ago

Sanofi

FR
•
Pharmaceutical Preparation Manufacturing
Updated about 22 hours ago

OrthogenRx, Inc.

US
•
Health and social work services (85)
Updated about 2 months ago

Procter And Gamble

US
•
Chemicals nec
Updated 2 days ago

Warner Chilcott plc

IE
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Fidia Farmaceutici S.P.A.

IT
•
Pharmaceutical Preparation Manufacturing
Updated about 2 months ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251030.2
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy